Evidence map›Paper›PMID 27488349›Full record

ArticleBlood2016

A recurring mutation in the respiratory complex 1 protein NDUFB11 is responsible for a novel form of X-linked sideroblastic anemia.

Daniel A Lichtenstein, Andrew W Crispin, Anoop K Sendamarai, Dean R Campagna, Klaus Schmitz-Abe, Cristovao M Sousa, Martin D Kafina, Paul J Schmidt, Charlotte M Niemeyer, John Porter and 8 more

Abstract read
In one paragraph

Article in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Splicing factor mutations in MDS RARS and MDS/MPN-RS-T.International journal of hematology · 2017
    Review
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Daniel A LichtensteinDepartment of Pathology and.
Andrew W CrispinDepartment of Pathology and.
Anoop K SendamaraiDepartment of Pathology and.
Dean R CampagnaDepartment of Pathology and.
Klaus Schmitz-AbeDivision of Genetics and Genomics, Boston Children's Hospital, Boston, MA.
Cristovao M SousaDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA.
Martin D KafinaDivision of Hematology, Brigham and Women's Hospital and Boston Children's Hospital, Boston, MA.
Paul J SchmidtDepartment of Pathology and.
Charlotte M NiemeyerDepartment for Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
John PorterDivision of Haematology, King's College, London, United Kingdom.
Alison MayDepartment of Haematology, Cardiff University School of Medicine, Cardiff, United Kingdom.
Mrinal M PatnaikDivision of Hematology-Oncology, Mayo Clinic, Rochester, MN.
Matthew M HeeneyDana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
Alec KimmelmanDepartment of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA; Department of Radiation Oncology, New York University Langone Cancer Center, New York, NY; and.
Sylvia S BottomleyUniversity of Oklahoma College of Medicine, Oklahoma City, OK.
Barry H PawDivision of Hematology, Brigham and Women's Hospital and Boston Children's Hospital, Boston, MA.
Kyriacos MarkianosDepartment of Pathology and.
Mark D FlemingDepartment of Pathology and.

Funding

TRANSCRIPTION FACTOR GATA-1 IN TERMINAL ERYTHROID DEVELOPMENTP01HL032262 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1985 to 2021
$38.9M
Molecular Genetics of Sideroblastic AnemiaR01DK087992 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI FLEMING, MARK D · 2011 to 2015
$2.0M
Frascati: mitochondrial transporter and erythropoiesisR01DK070838 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI PAW, BARRY H · 2007 to 2011
$1.8M
NHLBI NIH HHS P01 HL032262NIDDK NIH HHS R01 DK070838NIDDK NIH HHS R01 DK087992
6 · The paper itself

Abstract

The congenital sideroblastic anemias (CSAs) are a heterogeneous group of inherited blood disorders characterized by pathological mitochondrial iron deposition in erythroid precursors. Each known cause has been attributed to a mutation in a protein associated with heme biosynthesis, iron-sulfur cluster biogenesis, mitochondrial translation, or a component of the mitochondrial respiratory chain. Here, we describe a recurring mutation, c.276_278del, p.F93del, in NDUFB11, a mitochondrial respiratory complex I-associated protein encoded on the X chromosome, in 5 males with a variably syndromic, normocytic CSA. The p.F93del mutation results in respiratory insufficiency and loss of complex I stability and activity in patient-derived fibroblasts. Targeted introduction of this allele into K562 erythroleukemia cells results in a proliferation defect with minimal effect on erythroid differentiation potential, suggesting the mechanism of anemia in this disorder.

Indexed as

Base SequenceSequence DeletionAdolescentAdultAgedAnemia, SideroblasticChildChild, PreschoolChromosomes, Human, XElectron Transport Complex IFemaleGenetic Diseases, X-LinkedHumansK562 CellsMaleMiddle AgedElectron Transport Complex INDUFB11 protein, human

Identifiers

PMID27488349
PMCPMC5064715

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.